⌕
Ibotta · IBTA · NYSE
Tenet 44 · Weak
Compare
$48.68+0.14%At closeTenet 44 · Weak
$48.68+0.07 (+0.14%)
At close: Oct 26, 2026, 4:00 PM ET· NYSE · USD

Ibotta (IBTA) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 6.8% in FY25, net margin 1.0%, and free cash flow (~$61.0M) tracks net income. Earnings are cash, not paper. Worth your attention in FY25: Share count (+247.1%) and Capex step-up ($34.3M). Both visible in the receipts below.
The four lines that matter · FY22–FY25
Revenue ($M)▼6.8%
342.4
FY22→FY25CAGR +17.6%/yr
Net income ($M)▼94.8%
3.6
FY22→FY25CAGR —
Free cash flow ($M)▼42.3%
61.0
capex stepped upCAGR —
Diluted EPS▼95.3%
0.12
FY22→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+247.1%

8.7mn → 30.1mn diluted shares since FY22. Rising share count dilutes EPS. Growth must outrun it.

Capex step-up
$34.3M

▲236% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

Returns vs FCF
382%

$233.0M returned vs $61.0M of FCF in FY25. The gap comes off the balance sheet (see net cash).

What the income statement says · FY22–FY25
Where every revenue dollar goes · FY25 ($K)342389.0Revenue−71055.0COGS271334.0Gross profit−61082.0R&D−88244.0SG&A−841.0Op income4416.0Tax & other3575.0Net income

1¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
906845230%sector median net margin ~7%FY22FY25

Over this window: gross 78.1% → 79.2%. Net margin 1.0% is below the sector median.

The receipt · income statement · FY22–FY25 USD thousands except per-share & ratios · hover a line for its definition
The annual and quarterly statements are struck on share counts that differ by a factor of 1.293, so per-share figures cannot be compared across the two tables. Each table's per-share figures are on its own share basis.
USD thousands except per-share & ratios
Line itemTTM †FY25FY24FY23FY22YoYCAGR 22→25
Revenue & profitability
Revenue
343,174.0342,389.0367,254.0320,037.0210,702.0▼6.8%+17.6%
Cost of revenue
74,674.071,055.050,121.043,992.046,176.0▲41.8%+15.4%
Gross profit
268,500.0271,334.0317,133.0276,045.0164,526.0▼14.4%+18.1%
Research & development
57,843.061,082.063,271.049,996.042,558.0▼3.5%+12.8%
Selling, general & admin
90,145.088,244.082,739.051,633.049,164.0▲6.7%+21.5%
Total operating expenses
280,485.0272,175.0289,208.0220,046.0204,839.0▼5.9%+9.9%
Operating incomefeeds ROC rank
−11,985.0−841.027,925.055,999.0−40,313.0——
Other income, net
7,596.010,688.0−3,429.0−11,948.0−14,286.0——
Pretax income
−4,389.09,847.024,496.044,051.0−54,599.0▼59.8%—
Income tax
6,632.06,272.0−44,246.05,934.0262.0—+188.2%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
−11,021.03,575.068,742.038,117.0−54,861.0▼94.8%—
Per share
Diluted EPSbuyback-sensitive
−0.460.122.561.42−6.33▼95.3%—
Diluted shares (mn)
23.2830.1026.8626.928.67▲12.1%+51.4%
Margins
Gross margin91st pct in Industrials
78.2%79.2%86.4%86.3%78.1%▼7.1pp+1.2pp
Operating margin
−3.5%−0.2%7.6%17.5%−19.1%▼7.8pp+18.9pp
Net margin20th pct in Industrials
−3.2%1.0%18.7%11.9%−26.0%▼17.7pp+27.1pp
† TTM = trailing four quarters through 2026-06-30.
CSV export is on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-25 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Ibotta's revenue last fiscal year?

Ibotta reported revenue of $342.4M in fiscal 2025, down 6.8% from fiscal 2024.

What was Ibotta's net income?

Ibotta reported net income of $3.6M in fiscal 2025, a net margin of 1.0%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.